title: Misunderstanding of asthma controller medications: association with nonadherence.
abstract: OBJECTIVE
  Nonadherence to regular inhaled anti-inflammatory medication use is a frequent contributor to poor control of persistent asthma and may result from misunderstanding of the preventive role of such medications. This study's aims are to 1) test the hypothesis that misunderstanding is associated with decreased adherence to its daily use and 2) identify factors associated with increased risk of misunderstanding.
  
  
  METHODS
  A sample of parents of children with asthma insured by Medicaid and enrolled in managed care programs in Northern California, Washington, and Massachusetts were interviewed by telephone. This analysis focused on the subset that reported having an inhaled anti-inflammatory medication and whose medication use and symptom frequency in the 2 weeks before the interview suggested persistent asthma. Misunderstanding of the role of inhaled anti-inflammatory medication was defined as identifying it as being for treatment of symptoms after they begin and not for prevention of symptoms before they start.
  
  
  RESULTS
  A total of 1663 parents of children with asthma (63% response rate) were interviewed. Of those, 571 subjects (34%) reported use of an inhaled anti-inflammatory medication and met our criteria for persistent asthma. Among those with persistent asthma, 23% (131 parents) misunderstood the role of their child's inhaled anti-inflammatory. Misunderstanding of inhaled anti-inflammatory medication was associated with decreased adherence to its daily use (odds ratio [OR] 0.18, 95% confidence interval [CI], 0.11-0.29). The risk for misunderstanding was lower if the patient had seen a specialist (OR 0.42, 95% CI, 0.24-0.75) or had graduated high school (OR=0.54, 95% CI, 0.34-0.84).
  
  
  CONCLUSIONS
  Misunderstanding of the role of inhaled anti-inflammatory medication is associated with reduced adherence to its daily use.
authors.affiliation: Department of Pediatrics, Kaiser Permanente Vallejo Medical Center, Vallejo, California 94589, USA. harold.j.farber@kp.org
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Farber
authors.forename: Angela M
authors.initials: AM
authors.lastname: Capra
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Finkelstein
authors.forename: Paula
authors.initials: P
authors.lastname: Lozano
authors.forename: Charles P
authors.initials: CP
authors.lastname: Quesenberry
authors.forename: Nancy G
authors.initials: NG
authors.lastname: Jensvold
authors.forename: Felicia W
authors.initials: FW
authors.lastname: Chi
authors.forename: Tracy A
authors.initials: TA
authors.lastname: Lieu
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy / Q000517:prevention & control*; D002648:Child; D003142:Communication; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007407:Interviews as Topic; D008329:Managed Care Programs; D008484:Medicaid; D010290:Parents / Q000523:psychology*; D010349:Patient Compliance; D014481:United States
chemical_list: D018927:Anti-Asthmatic Agents